RADIUM (223RA) DICHLORIDE

DRUG2 trials

Sponsors

Karolinska Institutet, Azienda Ospedaliera Universitaria Policlinico Paolo Giaccone

Conditions

Prostate CancerSymptomatic bone metastases from breast cancer

Phase 2

Radium223 dichloride (223RaCl) in the treatment of symptomatic bone metastases from breast cancer.

Not yet recruitingCTIS2025-524208-31-00

Azienda Ospedaliera Universitaria Policlinico Paolo GiacconeSymptomatic bone metastases from breast cancer

Target: 50Updated: 2026-06-08

Phase 3

ProBio: An outcome-adaptive and randomised multi-arm biomarker driven study in patients with metastatic prostate cancer

RecruitingCTIS2023-506857-40-00

Karolinska InstitutetProstate Cancer

Start: 2019-01-08Target: 1750Updated: 2025-12-15